Phil Gutry
Director, Avalo Therapeutics, Inc.
Companies
- LENZ Therapeutics, Inc.CHIEF BUSINESS OFFICER Jun 24, 2021 to Apr 13, 20221
- Avalo Therapeutics, Inc.Board member Oct 14, 2015 to Dec 3, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- LENZ Therapeutics, Inc. LENZ299,941 shares3$1.1M at $3.57Apr 11, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 11, 2022Bought 5,000 shares at $4.01 of LENZ Therapeutics, Inc.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3